Mission Statement

We are dedicated to rapidly advance life-changing therapies that address the unmet need of serious and complex mitochondrial diseases. We are the first company to develop a cell therapy approach to treat a broad range of indications generated by a mitochondrial dysfunction. Using our proprietary Mitochondrial Augmentation Technology (MAT), designed to be a robust therapeutic platform combining personalized mitochondrial cell therapy and scalable manufacturing processes, we are advancing breakthrough therapies for patients with mitochondrial dysfunction, caused by disease as well as during aging.

On the web